Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, an... Incannex Healthcare Ltd is developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. Mehr anzeigen
NEW YORK and MELBOURNE, Australia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company developing innovative...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 4.89130434783 | 1.84 | 1.93 | 1.71 | 16032 | 1.79076287 | CS |
| 4 | 0.15 | 8.42696629213 | 1.78 | 2.2447 | 1.65 | 25035 | 1.94770326 | CS |
| 12 | -0.31 | -13.8392857143 | 2.24 | 3.1199 | 1.6 | 28787 | 2.19032543 | CS |
| 26 | -0.66 | -25.4826254826 | 2.59 | 3.1199 | 1.5 | 29322 | 2.03410974 | CS |
| 52 | -2.84 | -59.5387840671 | 4.77 | 8.4697 | 1.5 | 100218 | 4.97553204 | CS |
| 156 | -9.07 | -82.4545454545 | 11 | 90 | 0.8 | 73811 | 6.75784217 | CS |
| 260 | -9.07 | -82.4545454545 | 11 | 90 | 0.8 | 73811 | 6.75784217 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
